Renal Dernavation May be Cost-Effective for Treating High Blood Pressure
Published date : 17 September 2012
Article date : 17 September 2012
An article in Mass Device reports on a study published in the Journal of the American College of Cardiology which claims that renal denervation is a cost-effective treatment for high blood pressure.
Apparently, the data leading to the latest conclusions has resulted from Medtronic's Symplicity HTN 2 renal denervation trial. The study showed that the catheter-based technique where doctors blast the nerves lining the renal artery with radiofequency energy could be substantially cheaper and more effective than the current standard of care.
Source: Mass Device, 13 September 2012
Read the full article here
